CLINICAL_TRIALS
trial_result
· 2021-12-14
Clinical Trial Update: A Study of S5G4T-1 in the Treatment of Papulopustular Rosacea [Phase 3]
Summary
Phase 3 trial of S5G4T-1 for papulopustular rosacea has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sol-Gel Technologies, Ltd. | Conditions: Papulopustular Rosacea | Phase 3 | Status: COMPLETED | Results posted: 2021-12-14